Published online before print May 12, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Medical Microbiology and Immunology and the M.I.N.D. Institute and
Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis, Sacramento
1 Correspondence: M.I.N.D. Institute, UC Davis, Wet Lab Building, 50th Street, Sacramento, CA 95817. E-mail: pashwood{at}ucdavis.edu
Autism spectrum disorders (ASD) are part of a broad spectrum of neurodevelopmental disorders known as pervasive developmental disorders, which occur in childhood. They are characterized by impairments in social interaction, verbal and nonverbal communication and the presence of restricted and repetitive stereotyped behaviors. At the present time, the etiology of ASD is largely unknown, but genetic, environmental, immunological, and neurological factors are thought to play a role in the development of ASD. Recently, increasing research has focused on the connections between the immune system and the nervous system, including its possible role in the development of ASD. These neuroimmune interactions begin early during embryogenesis and persist throughout an individual’s lifetime, with successful neurodevelopment contingent upon a normal balanced immune response. Immune aberrations consistent with a dysregulated immune response, which so far, have been reported in autistic children, include abnormal or skewed T helper cell type 1 (TH1)/TH2 cytokine profiles, decreased lymphocyte numbers, decreased T cell mitogen response, and the imbalance of serum immunoglobulin levels. In addition, autism has been linked with autoimmunity and an association with immune-based genes including human leukocyte antigen (HLA)-DRB1 and complement C4 alleles described. There is potential that such aberrant immune activity during vulnerable and critical periods of neurodevelopment could participate in the generation of neurological dysfunction characteristic of ASD. This review will examine the status of the research linking the immune response with ASD.
Key Words: autism spectrum disorder (ASD) • neurodevelopment • neurokine • immunity • inflammation • cytokines
This article has been cited by other articles:
 |
|
 |
|
  J. S. Mader, N. Mookherjee, R. E.W. Hancock, and R. C. Bleackley The Human Host Defense Peptide LL-37 Induces Apoptosis in a Calpain- and Apoptosis-Inducing Factor-Dependent Manner Involving Bax Activity Mol. Cancer Res., May 1, 2009; 7(5): 689 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tuke, G. F. V. Glonek, and P. J. Solomon Gene profiling for determining pluripotent genes in a time course microarray experiment Biostat., January 1, 2009; 10(1): 80 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Trajkovski, A. Petlichkovski, O. Efinska-Mladenovska, D. Trajkov, T. Arsov, A. Strezova, L. Ajdinski, and M. Spiroski Higher Plasma Concentration of Food-Specific Antibodies in Persons With Autistic Disorder in Comparison to Their Siblings Focus on Autism and Other Developmental Disabilities, September 1, 2008; 23(3): 176 - 185. [Abstract] [PDF]
|
|
|
|
 |
|
 Z. Zhou, M. F. Bolontrade, K. Reddy, X. Duan, H. Guan, L. Yu, D. J. Hicklin, and E. S. Kleinerman Suppression of Ewing's Sarcoma Tumor Growth, Tumor Vessel Formation, and Vasculogenesis Following Anti Vascular Endothelial Growth Factor Receptor-2 Therapy Clin. Cancer Res., August 15, 2007; 13(16): 4867 - 4873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Smith, N. E. Mangan, C. M. Walsh, R. E. Fallon, A. N. J. McKenzie, N. van Rooijen, and P. G. Fallon Infection with a Helminth Parasite Prevents Experimental Colitis via a Macrophage-Mediated Mechanism J. Immunol., April 1, 2007; 178(7): 4557 - 4566. [Abstract] [Full Text] [PDF]
|
|
